Karger Publishers
Browse
Supplementary material-Supplemental_Material.doc (101.5 kB)

Supplementary Material for: A de novo PRPF8 pathogenic variant in transient severe hypophosphatemia with delayed puberty and growth failure

Download (101.5 kB)
dataset
posted on 2024-07-08, 04:31 authored by Koljonen L., Salonen P., Rusanen S., Mäyränpää M.K., Pekkinen M., Mäkitie O.
Introduction: Childhood hypophosphatemia is a rare condition and may be caused by malabsorption, malignancies, or genetic factors. Prolonged hypophosphatemia leads to impaired growth and radiographic signs of rickets. Methods: We performed a detailed clinical and genetic evaluation of an adolescent boy with repeatedly low plasma phosphate concentrations (below 0.60 mmol/L), and growth failure. Results: At 14 years, the patient presented with decelerating growth and delayed puberty. Biochemistry showed hypophosphatemia due to increased urinary phosphate loss; kidney function and vitamin D status were normal. Radiographs showed mild metaphyseal changes. A gene panel for known genetic hypophosphatemias was negative. Trio exome analysis followed by Sanger sequencing identified a pathogenic heterozygous de novo stop gain variant in PRPF8 gene, c.5548C>T p.(Arg1850*)., in the conserved RNase H homology domain. PRPF8 encodes the pre-RNA protein 8, which has a role in RNA processing. Heterozygous PRPF8 variants have been associated with retinitis pigmentosa and neurodevelopmental disorders but not with phosphate metabolism. The patient underwent growth hormone (GH) stimulation tests which confirmed GH deficiency. Head MRI indicated partially empty sella. GH treatment was started at 15 years. Surprisingly, phosphate metabolism normalized during GH treatment, suggesting that hypophosphatemia was at least partly secondary to growth hormone deficiency. Conclusion: In conclusion, the evaluation of an adolescent with profound long-term hypophosphatemia revealed a pituitary developmental defect associated with a stop gain variant in PRPF8. Hypophosphatemia alleviated with GH treatment. The pathological PRPF8 variant may contribute to abnormal pituitary development; however, its role in phosphate metabolism remains uncertain.

History

Usage metrics

    Hormone Research in Paediatrics

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC